SCA
CVS icon

Snowden Capital Advisors’s CVS Health CVS Stock Holding History

Snowden Capital Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.57M Sell
77,560
-11,898
-13% -$917K 0.15% 153
2025
Q4 		$7.1M Buy
89,458
+2,571
+3% +$203K 0.18% 109
2025
Q3 		$6.55M Buy
86,887
+1,852
+2% +$127K 0.18% 108
2025
Q2 		$5.87M Sell
85,035
-91
-0.1% -$5.97K 0.17% 124
2025
Q1 		$5.77M Buy
85,126
+25,125
+42% +$1.5M 0.18% 120
2024
Q4 		$2.69M Sell
60,001
-11,880
-17% -$666K 0.08% 238
2024
Q3 		$4.52M Sell
71,881
-6,161
-8% -$359K 0.13% 187
2024
Q2 		$4.61M Sell
78,042
-4,419
-5% -$276K 0.14% 184
2024
Q1 		$6.58M Sell
82,461
-51,702
-39% -$3.95M 0.21% 110
2023
Q4 		$10.6M Sell
134,163
-4,934
-4% -$351K 0.4% 40
2023
Q3 		$9.71M Sell
139,097
-7,785
-5% -$552K 0.41% 39
2023
Q2 		$10.2M Buy
146,882
+20,622
+16% +$1.47M 0.36% 48
2023
Q1 		$9.38M Buy
126,260
+9,855
+8% +$826K 0.36% 45
2022
Q4 		$10.8M Buy
116,405
+2,103
+2% +$203K 0.45% 31
2022
Q3 		$10.9M Sell
114,302
-2,177
-2% -$215K 0.49% 32
2022
Q2 		$10.8M Sell
116,479
-7,617
-6% -$743K 0.48% 34
2022
Q1 		$12.6M Buy
124,096
+9,227
+8% +$969K 0.5% 37
2021
Q4 		$11.8M Sell
114,869
-7,202
-6% -$666K 0.61% 26
2021
Q3 		$10.4M Buy
122,071
+7,067
+6% +$592K 0.52% 33
2021
Q2 		$9.6M Buy
115,004
+2,933
+3% +$240K 0.48% 38
2021
Q1 		$8.43M Buy
112,071
+16,181
+17% +$1.18M 0.48% 38
2020
Q4 		$6.55M Buy
95,890
+5,320
+6% +$346K 0.43% 51
2020
Q3 		$5.29M Buy
90,570
+2,684
+3% +$167K 0.42% 65
2020
Q2 		$5.71M Buy
87,886
+267
+0.3% +$16.8K 0.49% 44
2020
Q1 		$5.2M Sell
87,619
-8,405
-9% -$561K 0.57% 32
2019
Q4 		$7.13M Buy
96,024
+15,354
+19% +$1.08M 0.63% 26
2019
Q3 		$5.09M Sell
80,670
-1,082
-1% -$64.1K 0.51% 45
2019
Q2 		$4.45M Buy
81,752
+8,405
+11% +$453K 0.46% 52
2019
Q1 		$3.96M Buy
73,347
+38,775
+112% +$2.39M 0.43% 55
2018
Q4 		$2.27M Buy
34,572
+6,878
+25% +$513K 0.29% 116
2018
Q3 		$2.18M Buy
27,694
+960
+4% +$68.6K 0.25% 130
2018
Q2 		$1.72M Buy
26,734
+852
+3% +$56.1K 0.22% 158
2018
Q1 		$1.61M Buy
25,882
+6,424
+33% +$461K 0.24% 155
2017
Q4 		$1.41M Buy
19,458
+4,700
+32% +$342K 0.2% 170
2017
Q3 		$1.2M Buy
14,758
+1,875
+15% +$148K 0.19% 165
2017
Q2 		$1.04M Buy
12,883
+1,740
+16% +$137K 0.19% 162
2017
Q1 		$875K Buy
11,143
+4,338
+64% +$346K 0.19% 167
2016
Q4 		$537K Sell
6,805
-228
-3% -$18.4K 0.14% 188
2016
Q3 		$626K Buy
+7,033
New +$664K 0.17% 173
2016
Q2 		– Sell
-2,061
Closed -$214K – 277
2016
Q1 		$214K Buy
+2,061
New +$200K 0.07% 255

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Snowden Capital Advisors's CVS Position: Q1 2026 in Review

Snowden Capital Advisors reduced its CVS Health (CVS) stake by 13% in Q1 2026, selling an estimated $917K and leaving 77,560 shares worth $5.57M. The position accounts for 0.15% of the portfolio, ranked #153.

Snowden Capital Advisors first reported a position in CVS in Q1 2016 and has held it in 40 quarters since. The position peaked at $12.6M in Q1 2022. 1,867 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Snowden Capital Advisors held 77,560 shares of CVS Health worth $5.57M as of Q1 2026.
  • Snowden Capital Advisors sold 11,898 CVS Health shares in Q1 2026, an estimated $917K.
  • CVS Health made up 0.15% of Snowden Capital Advisors's portfolio in Q1 2026, its #153 holding.
  • Snowden Capital Advisors first reported a position in CVS Health in Q1 2016 and has held it in 40 quarters since.
  • Snowden Capital Advisors's CVS Health position peaked at $12.6M in Q1 2022.
  • 1,867 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Snowden Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.